Most neoplasms, including bladder cancer, are thought to progress through a series of clinical histopathological stages. This progression is accompanied by specific genetic changes, which include activation of protooncogenes and loss of tumor suppressor genes. Recently, we defined another major event in bladder cancer progression outside of the nucleus: mitochondrial mutation. Studies in this proposal are aimed at the characterization of mitochondrial mutations in the development of bladder cancer and ultimately in developing new molecular detection strategies. First, a variety of lesions, including preinvasive and invasive tumors will be tested to identify the frequency and nature of mitochondrial mutations to develop a mitochondrial molecular progression model for bladder cancer. Second, functional studies will continue to identify the nature and function of specific mitochondrial mutations to better understand their role in the neoplastic process. Finally, we will continue development of assays that can detect mitochondrial mutations in urine DNA. Initial feasibility projects demonstrate that these studies will be greatly accelerated with the advent of high throughput mitochondrial mutation detection based on polymorphism ratio Sequencing (PRS). A combination of the above studies should provide important insights into the mitochondrial alterations associated with bladder tumor progression and their role in the neoplastic process. Additionally, characterization of highly susceptible mitochondrial regions will allow integration of critical targets for further development of molecular detection approaches.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA077664-09
Application #
7550178
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
9
Fiscal Year
2008
Total Cost
$357,760
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Duberow, David P; Brait, Mariana; Hoque, Mohammad O et al. (2016) High-performance detection of somatic D-loop mutation in urothelial cell carcinoma patients by polymorphism ratio sequencing. J Mol Med (Berl) 94:1015-24
Ferguson, Lynnette R; Chen, Helen; Collins, Andrew R et al. (2015) Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol 35 Suppl:S5-S24
Bishop, Justin A; Yonescu, Raluca; Batista, Denise et al. (2013) Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma. Hum Pathol 44:1982-8
Kinde, Isaac; Munari, Enrico; Faraj, Sheila F et al. (2013) TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. Cancer Res 73:7162-7
Zhong, Xiaoli; Isharwal, Sumit; Naples, Jean M et al. (2013) Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection. PLoS One 8:e59089
Chaux, Alcides; Cohen, Julie S; Schultz, Luciana et al. (2012) High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues. Hum Pathol 43:1590-5
Dasgupta, Santanu; Shao, Chunbo; Keane, Thomas E et al. (2012) Detection of mitochondrial deoxyribonucleic acid alterations in urine from urothelial cell carcinoma patients. Int J Cancer 131:158-64
Chaux, Alcides; Karram, Sarah; Miller, Jeremy S et al. (2012) High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center. Hum Pathol 43:115-20
Begum, Shahnaz; Brait, Mariana; Dasgupta, Santanu et al. (2011) An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res 17:4494-503
Thaitrong, Numrin; Liu, Peng; Briese, Thomas et al. (2010) Integrated capillary electrophoresis microsystem for multiplex analysis of human respiratory viruses. Anal Chem 82:10102-9

Showing the most recent 10 out of 40 publications